Activated glucocorticoid receptor interacts with the INHAT component Set/TAF-Ibeta and releases it from a glucocorticoid-responsive gene promoter, relieving repression: implications for the pathogenesis of glucocorticoid resistance in acute undifferentiated leukemia with Set-Can translocation

Mol Cell Endocrinol. 2008 Feb 13;283(1-2):19-31. doi: 10.1016/j.mce.2007.10.014. Epub 2007 Nov 17.

Abstract

Set/template-activating factor (TAF)-Ibeta, part of the Set-Can oncogene product found in acute undifferentiated leukemia, is a component of the inhibitor of acetyltransferases (INHAT) complex. Set/TAF-Ibeta interacted with the DNA-binding domain of the glucocorticoid receptor (GR) in yeast two-hybrid screening, and repressed GR-induced transcriptional activity of a chromatin-integrated glucocorticoid-responsive and a natural promoter. Set/TAF-Ibeta was co-precipitated with glucocorticoid response elements (GREs) of these promoters in the absence of dexamethasone, while addition of the hormone caused dissociation of Set/TAF-Ibeta from and attraction of the p160-type coactivator GRIP1 to the promoter GREs. Set-Can fusion protein, on the other hand, did not interact with GR, was constitutively co-precipitated with GREs and suppressed GRIP1-induced enhancement of GR transcriptional activity and histone acetylation. Thus, Set/TAF-Ibeta acts as a ligand-activated GR-responsive transcriptional repressor, while Set-Can does not retain physiologic responsiveness to ligand-bound GR, possibly contributing to the poor responsiveness of Set-Can-harboring leukemic cells to glucocorticoids.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Chromatin Immunoprecipitation
  • Chromosomal Proteins, Non-Histone / genetics
  • Chromosomal Proteins, Non-Histone / metabolism*
  • DNA-Binding Proteins
  • Drug Resistance, Neoplasm / drug effects
  • Gene Expression Regulation, Neoplastic / drug effects
  • Glucocorticoids / pharmacology*
  • HCT116 Cells
  • Histone Acetyltransferases / metabolism
  • Histone Chaperones
  • Humans
  • Leukemia / pathology*
  • Ligands
  • Models, Genetic
  • Nuclear Proteins / metabolism
  • Oncogene Proteins, Fusion / metabolism*
  • Phosphoproteins / metabolism
  • Promoter Regions, Genetic / genetics*
  • Protein Binding / drug effects
  • Protein Structure, Tertiary
  • Rats
  • Receptors, Glucocorticoid / chemistry
  • Receptors, Glucocorticoid / genetics
  • Receptors, Glucocorticoid / metabolism*
  • Repressor Proteins / metabolism
  • Response Elements
  • Transcription Factors / genetics
  • Transcription Factors / metabolism*
  • Transcription, Genetic / drug effects
  • Translocation, Genetic* / drug effects

Substances

  • Chromosomal Proteins, Non-Histone
  • DNA-Binding Proteins
  • Glucocorticoids
  • Histone Chaperones
  • Ligands
  • Nuclear Proteins
  • Oncogene Proteins, Fusion
  • Phosphoproteins
  • Receptors, Glucocorticoid
  • Repressor Proteins
  • SET protein, human
  • SET-CAN fusion protein, human
  • Transcription Factors
  • Histone Acetyltransferases